Co-culture models of Pseudomonas aeruginosa biofilms grown on live human airway cells

Journal of Visualized Experiments

Volumn , Issue 44, 2010, Pages

  Moreau Marquis, Sophie ^a   Redelman, Carly V ^a   Stanton, Bruce A ^a   Anderson, Gregory G ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Airway; Biofilm; Cellular Biology; Co culture; Cystic Fibrosis; Cytotoxicity; Epithelial cells; Issue 44; Pseudomonas aeruginosa; Virulence

Indexed keywords

EID: 80355144017     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2186     Document Type: Article

References (17)

1. Anderson, G. G., Moreau-Marquis, S., Stanton, B. A. & O'Toole, G. A. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 76, 1423-1433 (2008).
2. Bruscia, E. et al. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther 9, 683-685 (2002).
3. Cozens, A. L. et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10, 38-47 (1994).
4. Hentchel-Franks, K. et al. Activation of airway cl-secretion in human subjects by adenosine. Am J Respir Cell Mol Biol 31, 140-146 (2004).
5. Moreau-Marquis, S. et al. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 295, L25-37 (2008).
6. Kuchma, S. L., Connolly, J. P. & O'Toole, G. A. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol 187 (2005).
7. Heydorn, A. et al. Experimental reproducibility in flow-chamber biofilms. Microbiology 146 (Pt 10), 2409-2415 (2000).
8. Heydorn, A. et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146 (Pt 10), 2395-2407 (2000).
9. Anderson, G. G., Yahr, T. L., Lovewell, R. R. & O'Toole, G. A. The Pseudomonas aeruginosa magnesium transporter MgtE inhibits transcription of the type III secretion system. Infect Immun 78 (2010).
10. Costerton, J. W. Overview of microbial biofilms. J Ind Microbiol 15, 137-140 (1995).
11. Hoiby, N., Frederiksen, B. & Pressler, T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 Suppl 2, 49-54 (2005).
12. Ko, Y. H. & Pedersen, P. L. Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease. J Bioenerg Biomembr 33, 513-521 (2001).
13. Gibson, R. L., Burns, J. L. & Ramsey, B. W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168, 918-951 (2003).
14. Furukawa, S., Kuchma, S. L. & O'Toole, G. A. Keeping their options open: acute versus persistent infections. J Bacteriol 188, 1211-1217 (2006).
15. Merritt, J. H., Kadouri, D. E. & O'Toole, G. A. Growing and analyzing static biofilms. Curr Protoc Microbiol Chapter 1, Unit 1B 1 (2005).
16. O'Toole, G. A. & Kolter, R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28, 449-461 (1998).
17. Gomez, M. I. & Prince, A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 7, 244-251 (2007).